ESRP2 and cancer: The difference in the impact of Esrp2 and Esrp1 overexpression on Cdh1 levels at day 5 is consistent with a previous study demonstrating that the knockdown of Esrp paralogs has different effects on Cdh1 expression in the context of cancer cell motility [38].